CD38 - Wikipedia
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis - ScienceDirect
Evolving roles of CD38 metabolism in solid tumour microenvironment | British Journal of Cancer
![PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c705fe469b5966b746cb77a8063ac6adff11c2ee/3-Figure1-1.png "PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar")
PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar
CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
CD38 and CD157: A long journey from activation markers to multifunctional molecules - Quarona - 2013 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
CD38, A Target for Immunotherapeutic Approaches in Cancer
Frontiers | CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
IJMS | Free Full-Text | Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
CD38: An important regulator of T cell function - ScienceDirect
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
Frontiers | CD38: A Significant Regulator of Macrophage Function
CD38 at the junction between prognostic marker and therapeutic target: Trends in Molecular Medicine
CD38 / CD19 / FIREFLY LUCIFERASE – CHO RECOMBINANT CELL LINE
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections - ScienceDirect
CD38: An important regulator of T cell function - ScienceDirect
Pathology Outlines - CD38
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide | Haematologica
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Frontiers | Targeting CD38 for acute leukemia
![PDF] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4314fe212f09142cbdf4b8e2141b1bc761f12601/5-Figure3-1.png "PDF] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar")